Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor | MicrobiomeTrials← Back to trialsNCT07549022
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-08Est. Completion: 2028-04
Enrollment target: 17 participants Locations- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Other microbiome trials you might be interested in
Malignant Solid TumorsOther Neoplasms Solid TumorsPediatric Solid TumorRefractory Solid TumorsSolid Tumor
Background:
Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors or…
Bethesda, United StatesEst. completion May 31, 2028
Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid TumorAdvanced Breast CancerMalignant Peripheral Nerve Sheath Tumor
Colorectal Neoplasms
Background:
Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. N…
Fairway, United StatesEst. completion Dec 31, 2027